P16 Expression in Human Breast Carcinoma and its Relationship to Clinicopathological Parameters.

Mohammadizadeh, Fereshteh; Nasri, Farnaz

Mohammadizadeh, Fereshteh; Nasri, Farnaz.

Afiliação

Mohammadizadeh F; Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Nasri F; Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Adv Biomed Res ; 12: 154, 2023.

Article em En | MEDLINE | ID: mdl-37564443

Palavras-chave

Breast cancer; cyclin-dependent kinase inhibitor p16; immunohistochemistry; prognosis

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410420
https://dx.doi.org/10.4103/abr.abr_180_22

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410420
https://dx.doi.org/10.4103/abr.abr_180_22

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article